Archive Coverage of Tisch MSRCNY publications and interviews. 2026(1)2024(1)2023(3)2022 & older (2) Explore the Archive 06.05.2024 FDA-Approved Phase II Stem Cell Treatment Trial Shows Significant and Diverse Improvements for Multiple Sclerosis (MS) Patients (opens in a new tab)
06.05.2024 FDA-Approved Phase II Stem Cell Treatment Trial Shows Significant and Diverse Improvements for Multiple Sclerosis (MS) Patients (opens in a new tab)
